What are the appropriate next steps in evaluation and management for a patient with a one‑year history of a large (~30 cm) abdominal mass extending to the left rib margin and lower right abdomen, presenting only with vague bloating?

Immediate Comprehensive Imaging with Pelvic Ultrasound and Tumor Marker Assessment

For a patient with a 1-year history of a large (~30 cm) abdominal mass extending to the left rib margin with only vague bloating, you must immediately obtain transvaginal and transabdominal pelvic ultrasound with Doppler, measure serum CA-125, and prepare for urgent gynecologic oncology referral—this presentation is highly concerning for advanced ovarian malignancy that has been neglected for far too long.

Critical Initial Evaluation

Imaging Protocol

The ACR Appropriateness Criteria 1, 2 establish that pelvic ultrasound (transvaginal + transabdominal + Doppler) is the mandatory first-line imaging for any suspected adnexal mass. Given the massive size (30 cm) and 1-year duration:

• Transabdominal ultrasound is essential because transvaginal views alone cannot adequately assess masses this large 1
• Color/Power Doppler must be included to evaluate vascularity of any solid components—this distinguishes benign from malignant lesions with high accuracy 1
• Look specifically for: solid components, papillary projections, irregular septations, ascites, and vascular flow patterns within solid areas 1, 3

Laboratory Assessment

Measure CA-125 immediately 3. While CA-125 is elevated in only ~50% of early ovarian cancer, it is elevated in approximately 85% of advanced disease 3. Given the size and duration, this is likely advanced disease if malignant. The combination of elevated CA-125 with suspicious ultrasound features dramatically increases malignancy probability 1.

Algorithmic Next Steps Based on Initial Findings

If Ultrasound Shows High-Risk Features

High-risk features include: solid components with internal vascularity, papillary projections, irregular thick septations, ascites, or bilateral masses 1, 3.

Immediate actions:

1. CT abdomen and pelvis with IV contrast for staging 1—this is the standard modality for staging suspected ovarian malignancy
2. Urgent gynecologic oncology referral 1—only 33% of women with ovarian cancer are appropriately referred to gynecologic oncologists initially, yet this is the second most important prognostic factor after stage 1
3. Do NOT perform laparoscopic management 4—the guidelines explicitly state laparoscopic management of potentially malignant masses is not recommended

If Ultrasound is Indeterminate

If ultrasound cannot definitively characterize the mass:

Order MRI pelvis with and without IV contrast 1, 2. MRI is the problem-solving modality when ultrasound is indeterminate, with 91% overall accuracy for distinguishing benign from malignant 1. MRI with contrast increases the posttest probability of correctly identifying malignancy to 80% in premenopausal and 95% in postmenopausal women 1.

Critical Pitfalls to Avoid

The One-Year Delay is Alarming

A mass this size present for one year represents either:

• Delayed diagnosis of advanced malignancy (most concerning)
• Benign mucinous cystadenoma (can grow to 30+ cm) 5
• Rare entities like desmoid fibromatosis or giant lipoma 6, 7, 8

The minimal symptoms (only vague bloating) do NOT exclude malignancy. Advanced ovarian cancer commonly presents with nonspecific symptoms including bloating, early satiety, and abdominal distension 3. The absence of severe symptoms should not provide false reassurance.

Surgical Planning Considerations

If malignancy is suspected, surgical approach through midline or paramedian incision is mandatory 4—not laparoscopy. The tumor should be removed intact with frozen section obtained 4. If ovarian malignancy is confirmed, meticulous surgical staging including:

• Bilateral pelvic and para-aortic lymph node dissection
• Peritoneal washings
• Omental sampling
• Inspection of entire peritoneal cavity 4

Approximately 31% of patients believed to have early-stage disease are upstaged with proper surgical staging, with 77% reclassified as stage III 4.

Referral Urgency

Patients with elevated CA-125 or imaging suggestive of malignancy have absolute indications for gynecologic oncology referral 4. Given the size and duration, this referral should occur within days, not weeks. Surgery by a qualified gynecologic oncologist dramatically improves outcomes 1.

Differential Diagnosis Considerations

While ovarian malignancy must be excluded first, the differential for a 30 cm abdominal mass includes:

• Ovarian cystadenoma (mucinous can reach this size and be benign) 5
• Ovarian malignancy (epithelial ovarian cancer, borderline tumor)
• Retroperitoneal masses (lipoma, sarcoma) 6
• Mesenteric/peritoneal masses 9
• Gastrointestinal stromal tumor (GIST) if arising from GI tract 10

The imaging algorithm above will help localize the organ of origin and characterize the mass appropriately 9, 11.

Summary Action Plan

1. Today: Order pelvic ultrasound (transvaginal + transabdominal + Doppler) and serum CA-125
2. Within 48 hours: Review imaging results
3. If high-risk features: CT abdomen/pelvis with contrast + urgent gynecologic oncology referral
4. If indeterminate: MRI pelvis with contrast, then gynecologic oncology consultation
5. Avoid: Laparoscopic approach, further delays, or dismissing concerns due to minimal symptoms

The combination of massive size (30 cm), one-year duration, and location makes this a medical urgency requiring immediate systematic evaluation and specialist involvement 4, 1, 3.